55.81
1.15%
-0.65
Dopo l'orario di chiusura:
55.69
-0.12
-0.22%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CVS Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Perché le azioni Cvs Health Corp (CVS) sono in ribasso?
Abbiamo notato un calo di 5.23% nelle azioni di Cvs Health Corp (CVS) durante la sessione di negoziazione di 2024-10-18. Sebbene ciò possa essere attribuito alla normale volatilità o a vari fattori interni ed esterni, tieni presente che stiamo monitorando attivamente la situazione e forniremo aggiornamenti tempestivi il prima possibile!
2024-05-01:
CVS Health Corp (CVS) stock plunged by 16.84% following the release of disappointing first-quarter earnings and revised guidance for the year. The company's diversified portfolio in pharmacy and health insurance faced challenges, leading to a significant market reaction.
- Revenue Analysis: Total revenue for CVS Health Corp increased by 3.7% year over year to $88.4 billion, falling short of analyst expectations. While revenue from the pharmacy and consumer wellness segment saw a modest increase of 2.9% to $28.7 billion, revenue from health services, including the pharmacy benefit manager, declined by 9.7% to $40.3 billion. Notably, the healthcare benefits segment experienced a 24.6% revenue increase to $32.2 billion. However, escalating costs due to heightened Medicare utilization and declining Medicare Advantage star ratings eroded profitability.
- Medicare Challenges: The surge in Medicare costs and a decline in star ratings significantly impacted CVS's healthcare benefits segment. The medical benefit ratio rose from 84.6% to 90.4%, resulting in a substantial decrease in adjusted operating income. Adjusted earnings per share plummeted from $2.20 in Q1 2023 to $1.31, significantly missing analysts' expectations.
- Guidance Adjustment: Management revised its adjusted earnings per share forecast for the full year from at least $8.30 to at least $7, well below analysts' consensus forecast of $8.28. This downward revision, coupled with trimmed revenue guidance, intensified market concerns about the company's profitability and bottom-line weakness.
2023-10-20:
CVS Health Corporation Stock (CVS) dropped by 2.21% from $70.61 to $69.05 in the trading on Friday October 20, 2023. The reason why CVS stock down today is due to medicine removal. The pharmacy chain said it would remove some over-the-counter allergy and cold medicines after a U.S. Food and Drug Administration committee said a main ingredient, phenylephrine, was ineffective when taken orally.
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):